Arterial wave energy and recovery after balloon pulmonary angioplasty for CTEPH
Official title: Arterial Wave Energy Flux and Multidimensional Recovery in Patients With Chronic Thromboembolic Pulmonary Hypertension Undergoing Balloon Pulmonary Angioplasty
Run by Istanbul Mehmet Akif Ersoy Educational and Training Hospital · NCT07522203 · Data updated 2026-11-12
This tests whether advanced pulmonary artery pressure wave analysis can track and predict recovery in adults (18–85) with chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Istanbul Mehmet Akif Ersoy Educational and Training Hospital Government |
| Locations | 1 site (Istanbul) |
| Status | Recruiting |
| Started | March 10, 2026 |
| Main results expected | April 1, 2028 |
| Study ends | May 1, 2028 |
| Registry record updated | April 13, 2026 |
| Trial ID | NCT07522203 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–85 with confirmed CTEPH judged eligible for BPA (technically inoperable or persistent/recurrent PH after PEA) and hemodynamics consistent with pre-capillary PH who can give informed consent are ideal candidates.
✕Probably not a fit
Patients with predominant non-CTEPH pulmonary hypertension, severe parenchymal lung disease, uncontrolled comorbidities, poor-quality tracings or arrhythmias that prevent reliable waveform analysis, or contraindications to BPA or contrast are unlikely to benefit from these measurements.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective observational protocol that records pulmonary artery pressure waveforms during routine balloon pulmonary angioplasty and applies wave intensity analysis (WIA) and reservoir-excess pressure analysis (REPA). Patients receive standard-of-care BPA and undergo serial assessments including 6-minute walk distance, NT-proBNP, RV strain by echocardiography, and quality-of-life questionnaires. The waveform-derived pulsatile metrics will be compared to conventional steady-flow hemodynamics (mPAP, PVR) to see which metrics best track multidimensional clinical improvement. No extra invasive procedures are required beyond the catheter recordings obtained during planned BPA sessions.
Why it matters
Potential benefit: If successful, these waveform measures could give clinicians a more sensitive way to monitor and predict functional and right-heart recovery after BPA, allowing better tailored follow-up and treatment decisions.
How similar studies have gone: Wave-based hemodynamic methods have shown promise in systemic arterial research and small pulmonary studies, but applying WIA and REPA to predict BPA outcomes in CTEPH is largely novel with limited prior clinical data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Age 18-85 years.
Confirmed diagnosis of CTEPH by a multidisciplinary CTEPH team and deemed eligible for BPA.
Hemodynamics compatible with pre-capillary PH according to current guidelines, as assessed by RHC (Right Heart Catheterization).
Technically inoperable CTEPH or persistent/recurrent PH following PEA (Pulmonary Endarterectomy).
Written informed consent.
Exclusion Criteria:
* Predominant diagnosis of PH other than CTEPH or concomitant severe parenchymal lung disease.
Active infection, uncontrolled systemic disease, active malignancy, or life expectancy \< 12 months.
Pregnant or lactating patients.
Advanced renal failure (e.g., eGFR \< 30 \\text{ mL/min/1.73 m\^2}) or contraindications to contrast media (per institutional routine).
Inadequate image quality precluding reliable echocardiographic analysis.
Pressure tracings with significant artifacts hindering analysis or uncontrolled arrhythmia (e.g., atrial fibrillation with rapid ventricular response).
Decompensated or hemodynamically unstable patients.
Any other condition deemed clinically unsuitable by the investigator.
Where it's running
-
Istanbul Mehmet Akif Ersoy Educational and Training Hospital
Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Umit Bulut, MD
- Email: umit.bulut@saglik.gov.tr
- Phone: +90(212) 692 20 00
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
BMPR2-Activin signaling in pulmonary hypertension from left heart disease
This project will test whether changes in the BMPR2-activin pathway drive lung vessel disease in people with heart failure and pulmonary hypertension by following 150 patients for one year.
-
How balloon pulmonary angioplasty changes heart and lung blood flow measured by 4D CMR in CTEPH
The team will use 4D CMR scans before and after balloon pulmonary angioplasty to see if the procedure changes blood flow patterns and heart function in people with CTEPH.
-
Examining how biological sex affects heart function in CTEPH patients
This study looks at how being male or female affects heart function in people with chronic thromboembolic pulmonary hypertension (CTEPH) to see if there are any differences in their recovery after surgery.
-
Registry for patients with pulmonary hypertension and their treatment outcomes
This study is collecting information from patients with pulmonary hypertension who have just started treatment to see how well different therapies are working in real-life settings.
-
Add-on Sildenafil Before Exercise in PAH to See if Max Workload Improves
This study tests whether taking 20 mg sildenafil right before exercise helps people with pulmonary arterial hypertension perform more work during cardiopulmonary testing.
-
Nailfold Capillaroscopy in Pulmonary Hypertension
This study tests whether nailfold capillary scans correlate with invasive lung blood pressure measurements and whether these patterns change with PH treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.